Cath Lab

September 12, 2014 — Volcano Corp. announced it will be launching its interventional precision guidance tools at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, being held in Washington, D.C., Sept. 13-17.

Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new Medtronic CoreValve Evolut R System.

TCT 2014, late breaking trials, late breaking presentations

Transcatheter Cardiovascular Therapeutics (TCT) has announced the late-breaking trial presentations at TCT 2014, Sept. 13-17.

September 4, 2014 — Medtronic announced CE mark for the 23 mm CoreValve Evolut R system for transcatheter aortic valve implantation (TAVI). The novel self-expanding valve and 14 French equivalent delivery system offers new capabilities that advanc...

PARTNER I Trial TCT 2014 TAVR Heart Valve Repair
New data from a landmark clinical trial found that after five years, transcatheter aortic valve replacement (TAVR) demonstrated a persistent mortality benefit...
A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting of true coronary bifurcation lesions yields similar outcomes...
September 17, 2014 — A new clinical trial found that vascular closure devices (VCDs) are non-inferior to manual compression in patients undergoing transfemoral...
September 17, 2014 — GE Healthcare announced it has installed its Cath Lab Efficiency Manager at Saint Luke’s Mid America Heart Institute in Kansas City, Mo....
GE Healthcare's Cath Lab Efficiency Manager is a new analytical tool that analyzes the performance of an interventional lab, providing
Eizo Inc. expanded its U.S. Food and Drug Administration (FDA) 510(k)-cleared large monitor system with the addition of the RadiForce...
The easy-to-use online resource mHealth Roadmap includes information on implementation guidelines for mobile and mHealth...
Fysicon received approval from the U.S. Food and Drug Administration (FDA) to market Fysicon DataLinQ. The Fysicon DataLinQ products enable...

Articles

September 17, 2014 — A new clinical trial found that vascular closure devices (VCDs) are non-inferior to manual compression in patients undergoing transfemoral...
Medtronic U.S. Implants Clinical Study Recapturable CoreValve Evolut R
Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new...
Covidien TurboHawk Clinical Study Directional Atherectomy Effective PAD Therapy
Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien...
September 4, 2014 — Medtronic announced CE mark for the 23 mm CoreValve Evolut R system for transcatheter aortic valve implantation (TAVI). The novel self-...

Video Center

As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
2 weeks 20 hours ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
7 weeks 6 days ago
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
10 weeks 21 hours ago
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
This webinar demonstrates the Centricity Cardio Enterprise Solution (CCE), a solution that can help cardiology departments and hospital administrators to...